Your account is not claimed yet. You can sign up with ORCID to claim your account.

Stefan Schulz (S Schulz)

Scopus Author ID ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2018-2023
Publications (10 Years): 23

Top Venues

International journal of molecular sciences

Science signaling

Scientific reports

Nature communications

This page only lists publications with an associated author ORCID identifier.

Publications

Benjamin Wende, Anna-Sophia Liselott Beyer, Niklas Ruhnke, Daniel Kaemmerer, Jörg Sänger, Stefan Schulz, Amelie Lupp
Expression of the Calcitonin Receptor-like Receptor (CALCRL) in Normal and Neoplastic Tissues. International journal of molecular sciences 24 (4) (2023)
Mor Oron-Herman, David Kirmayer, Amelie Lupp, Stefan Schulz, Genady Kostenich, Michel Afargan
Expression prevalence and dynamics of GPCR somatostatin receptors 2 and 3 as cancer biomarkers beyond NET: a paired immunohistochemistry approach. Scientific reports 13 (1) (2023)
Benjamin Wende, Anna-Sophia Liselott Beyer, Niklas Ruhnke, Daniel Kaemmerer, Jörg Sänger, Stefan Schulz, Amelie Lupp
Expression of the Calcitonin Receptor-like Receptor (CALCRL) in Normal and Neoplastic Tissues. International journal of molecular sciences 24 (4) (2023)
Benjamin Wende, Anna-Sophia Liselott Beyer, Niklas Ruhnke, Daniel Kaemmerer, Jörg Sänger, Stefan Schulz, Amelie Lupp
Expression of the Calcitonin Receptor-like Receptor (CALCRL) in Normal and Neoplastic Tissues. International journal of molecular sciences 24 (4) (2023)
Evi Kostenis, Jesus Gomeza, Elke Miess-Tanneberg, Nina Kathleen Blum, Tobias Benkel, Andy Chevigné, Carsten Hoffmann, Peter Kolb, Viacheslav O Nikolaev, Maria Waldhoer, Martyna Szpakowska, Asuka Inoue, Stefan Schulz
Reply to: How carvedilol does not activate β 2 -adrenoceptors. Nature communications 14 (1) (2023)
Benjamin Wende, Anna-Sophia Liselott Beyer, Niklas Ruhnke, Daniel Kaemmerer, Jörg Sänger, Stefan Schulz, Amelie Lupp
Expression of the Calcitonin Receptor-like Receptor (CALCRL) in Normal and Neoplastic Tissues. International journal of molecular sciences 24 (4) (2023)
Sebastian Fritzwanker, Falko Nagel, Andrea Kliewer, Viviane Stammer, Stefan Schulz
In situ visualization of opioid and cannabinoid drug effects using phosphosite-specific GPCR antibodies. Communications biology 6 (1) (2023)
Daniela Modena, Maria Luisa Moras, Giovanni Sandrone, Andrea Stevenazzi, Barbara Vergani, Pooja Dasgupta, Andrea Kliewer, Sebastian Gulde, Alessandro Marangelo, Mathias Schillmaier, Raul Miguel Luque, Stephen Bäuerle, Natalia S Pellegata, Stefan Schulz, Christian Steinkühler
Identification of a Novel SSTR3 Full Agonist for the Treatment of Nonfunctioning Pituitary Adenomas. Cancers 15 (13) (2023)
Benjamin Wende, Anna-Sophia Liselott Beyer, Niklas Ruhnke, Daniel Kaemmerer, Jörg Sänger, Stefan Schulz, Amelie Lupp
Expression of the Calcitonin Receptor-like Receptor (CALCRL) in Normal and Neoplastic Tissues. International journal of molecular sciences 24 (4) (2023)
Julia Drube, Raphael S Haider, Edda Sofie Fabienne Matthees, M Reichel, J Zeiner, S Fritzwanker, C Ziegler, S Barz, L Klement, J Filor, V Weitzel, A Kliewer, E Miess-Tanneberg, Evi Kostenis, Stefan Schulz, Carsten Hoffmann
GPCR kinase knockout cells reveal the impact of individual GRKs on arrestin binding and GPCR regulation. Nature communications 13 (1) (2022)
Maria Bubb, Anna-Sophia Lieselott Beyer, Pooja Dasgupta, Daniel Kaemmerer, Jörg Sänger, Katja Evert, Ralph M Wirtz, Stefan Schulz, Amelie Lupp
Assessment of G Protein-Coupled Oestrogen Receptor Expression in Normal and Neoplastic Human Tissues Using a Novel Rabbit Monoclonal Antibody. International journal of molecular sciences 23 (9) (2022)
Johanna Kaufmann, Nina Kathleen Blum, Falko Nagel, Anna Schuler, Julia Drube, Carsten Degenhart, Julian Engel, Jan Eicke Eickhoff, Pooja Dasgupta, Sebastian Fritzwanker, Maria Guastadisegni, Clemens Schulte, Elke Miess-Tanneberg, Hans Michael Maric, Mariana Spetea, Andrea Kliewer, Matthias Baumann, Bert Klebl, Rainer K Reinscheid, Carsten Hoffmann, Stefan Schulz
A bead-based GPCR phosphorylation immunoassay for high-throughput ligand profiling and GRK inhibitor screening. Communications biology 5 (1) (2022)
Amelie Lupp, Blanca Ehms, Ralf Stumm, Johannes Göckeritz, Christian Mawrin, Stefan Schulz
Reassessment of SST4 Somatostatin Receptor Expression Using SST4-eGFP Knockin Mice and the Novel Rabbit Monoclonal Anti-Human SST4 Antibody 7H49L61. International journal of molecular sciences 22 (23) (2021)
Pooja Dasgupta, Thomas Gűnther, Stefan Schulz
Pharmacological Characterization of Veldoreotide as a Somatostatin Receptor 4 Agonist. Life (Basel, Switzerland) 11 (10) (2021)
Sebastian Fritzwanker, Stefan Schulz, Andrea Kliewer
SR-17018 Stimulates Atypical µ-Opioid Receptor Phosphorylation and Dephosphorylation. Molecules (Basel, Switzerland) 26 (15) (2021)
Sebastian Fritzwanker, Lionel Mouledous, Catherine Mollereau, Carine Froment, Odile Burlet-Schiltz, Felix Effah, Alexis Bailey, Mariana Spetea, Rainer K Reinscheid, Stefan Schulz, Andrea Kliewer
HA-MOP knockin mice express the canonical µ-opioid receptor but lack detectable splice variants. Communications biology 4 (1) (2021)
Anika Mann, Sophia Liebetrau, Marie Klima, Pooja Dasgupta, Dominique Massotte, Stefan Schulz
Agonist-induced phosphorylation bar code and differential post-activation signaling of the delta opioid receptor revealed by phosphosite-specific antibodies. Scientific reports 10 (1) (2020)
Alexander Gillis, Arisbel B Gondin, Andrea Kliewer, Julie Sanchez, Herman D Lim, Claudia Alamein, Preeti Manandhar, Marina Santiago, Sebastian Fritzwanker, Frank Schmiedel, Timothy A Katte, Tristan A Reekie, Natasha L Grimsey, Michael Kassiou, Barrie Kellam, Cornelius Krasel, Michelle L Halls, Mark Connor, J Robert Lane, Stefan Schulz, Macdonald J Christie, Meritxell Canals
Low intrinsic efficacy for G protein activation can explain the improved side effect profiles of new opioid agonists. Science signaling 13 (625) (2020)
A Kliewer, F Schmiedel, S Sianati, A Bailey, J T Bateman, E S Levitt, J T Williams, Macdonald J Christie, Stefan Schulz
Phosphorylation-deficient G-protein-biased μ-opioid receptors improve analgesia and diminish tolerance but worsen opioid side effects. Nature communications 10 (1) (2019)
Rebekka Mai, Daniel Kaemmerer, Tina Träger, Elisa Neubauer, Jörg Sänger, Richard P Baum, Stefan Schulz, Amelie Lupp
Different somatostatin and CXCR4 chemokine receptor expression in gastroenteropancreatic neuroendocrine neoplasms depending on their origin. Scientific reports 9 (1) (2019)
Akiko Nakai, Jun Fujimoto, Haruhiko Miyata, Ralf Stumm, Masashi Narazaki, Stefan Schulz, Yoshihiro Baba, Atsushi Kumanogoh, Kazuhiro Suzuki
The COMMD3/8 complex determines GRK6 specificity for chemoattractant receptors. The Journal of experimental medicine 216 (7) (2019)
Anika Mann, Lionel Mouledous, Carine Froment, Patrick R O'Neill, Pooja Dasgupta, Thomas Günther, Gloria Brunori, Brigitte L Kieffer, Lawrence Toll, Michael R Bruchas, Nurulain T Zaveri, Stefan Schulz
Agonist-selective NOP receptor phosphorylation correlates in vitro and in vivo and reveals differential post-activation signaling by chemically diverse agonists. Science signaling 12 (574) (2019)
Elke Miess, Arisbel B Gondin, Arsalan Yousuf, Ralph Steinborn, Nadja Mösslein, Yunshi Yang, Martin Göldner, Julia G Ruland, Moritz Bünemann, Cornelius Krasel, Macdonald J Christie, Michelle L Halls, Stefan Schulz, Meritxell Canals
Multisite phosphorylation is required for sustained interaction with GRKs and arrestins during rapid μ-opioid receptor desensitization. Science signaling 11 (539) (2018)

Stefan Schulz.css-eqlu8i{font-size:small;padding-left:4px;} (S Schulz)

Publication Activity (10 Years)

Top Topics

Top Venues

Stefan Schulz (S Schulz)